Medical Device Manufacturing Equipment (by Production) Market worth $27.80 billion by 2030 with 7.6% CAGR | MarketsandMarkets™
DELRAY BEACH, Fla., Sept. 18, 2025 /PRNewswire/ -- The global medical device manufacturing equipment market, valued at US$18.0 billion in 2024, stood at US$19.24 billion in 2025 and is projected to advance at a resilient CAGR of 7.6% from 2025 to 2030, culminating in a forecasted valuation of US$27.80 billion by the end of the period. The medical device manufacturing equipment (by production) market is driven by advancements in automation, robotics, and precision machining, along with increasing demand for high-quality, regulatory-compliant devices. Growth is restrained by high capital investment requirements, stringent regulatory standards, and supply chain complexities. Key opportunities exist in emerging markets with rising healthcare infrastructure investments, adoption of additive manufacturing/3D printing for customized devices, and integration of digital technologies like IoT and AI, enabling efficient, scalable, and flexible production to meet global demand.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=11106438
Browse in-depth TOC on "Medical Device Manufacturing Equipment (by Production) Market"
354 - Tables
51 - Figures
348 - Pages
By product, Material processing equipment is estimated to account for the largest market share as it is fundamental to shaping, cutting, welding, and assembling medical devices with high precision and reliability. Growing demand for minimally invasive devices, stringent quality standards, and the need for automation in production further strengthen its dominance, making it indispensable across diverse medical device manufacturing applications worldwide.
By production, Consumables & disposables is estimated to be the largest market as they are essential in every stage of medical device manufacturing, ensuring sterility, precision, and regulatory compliance. Their recurring demand, single-use nature, and critical role in maintaining production efficiency and safety drive consistent growth, making them a dominant and irreplaceable segment within the medical device manufacturing equipment (by production) market.
By geography, Europe holds the largest market share due to its strong base of established medical device OEMs, advanced manufacturing infrastructure, and stringent regulatory standards that drive adoption of high-quality equipment. Significant R&D investments, supportive government initiatives, and high healthcare expenditure further reinforce Europe's leadership in the medical device manufacturing equipment (by production) market, ensuring consistent demand and technological advancements.
Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=11106438
Prominent players in the medical device manufacturing equipment (by production) market are STERIS (US), Nordson Corporation (US), ENGEL (Austria), Zeiss Group (Germany), Multivac (Germany), Coherent Corp. (US), KUKA AG (Germany), ABB (Switzerland), TRUMPF (Germany), OC Oerlikon Management AG (Switzerland), Arburg (Germany), Stratasys Ltd (US), Plasmatreat (Germany), Nikon Corporation (Japan), and Mitutoyo Corporation (Japan), among others.
ABB (Switzerland):
ABB (Switzerland) holds a significant market share in the medical device manufacturing equipment (production) market due to its strong expertise in automation, robotics, and digital solutions that enhance precision and efficiency in device production. The company's advanced robotic arms and automation platforms are widely adopted by medical device manufacturers for assembly, packaging, and cleanroom-compatible processes, ensuring compliance with strict regulatory standards. ABB's focus on Industry 4.0 and smart factory solutions allows manufacturers to achieve higher throughput and cost optimization. Additionally, ABB's global service network and strong presence in regulated markets strengthen customer trust and sustain its leadership position.
STERIS (US)
STERIS (US) secures the second-largest market share in the medical device manufacturing equipment (production) market due to its strong specialization in sterilization, contamination control, and cleanroom solutions—critical aspects of medical device production. The company provides advanced sterilizers, washers, and decontamination systems that ensure product safety and regulatory compliance across global manufacturing facilities. Its integration of automation with cleaning and sterilization equipment streamlines production workflows and minimizes downtime. With a global customer base, robust after-sales services, and proven expertise in meeting FDA and ISO standards, STERIS plays a pivotal role in supporting reliable and efficient medical device manufacturing operations worldwide.
Zeiss Group (Germany)
Zeiss Group (Germany) holds the third-largest market share in the medical device manufacturing equipment (production) market due to its unmatched expertise in precision optics, metrology, and quality assurance solutions. The company's coordinate measuring machines, optical inspection systems, and microscopy technologies are vital for ensuring dimensional accuracy and compliance in medical device production. Zeiss's strong reputation for delivering high-precision equipment enables manufacturers to meet strict regulatory requirements and maintain product consistency. Its global reach, continuous innovation in optical and measurement technologies, and integration of digital solutions have further solidified its position as a trusted partner in the medical device production value chain.
For more information, Inquire Now!
Related Reports:
Top 10 Medical Device Technologies Market
Minimally Invasive Surgical Instruments Market
Get access to the latest updates on Medical Device Manufacturing Equipment Companies and Medical Device Manufacturing Equipment Market Size
About MarketsandMarkets™:
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg
Share this article